Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Authors
Keywords
Antimitotics, Tubulin, Taxanes, Paclitaxel, Docetaxel, Mechanisms of action, Resistance to taxanes, Surmounting drug resistance, ABC transporters
Journal
DRUG RESISTANCE UPDATES
Volume 54, Issue -, Pages 100742
Publisher
Elsevier BV
Online
2021-01-12
DOI
10.1016/j.drup.2020.100742
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner
- (2020) Lisa C. Hüsemann et al. CELL CYCLE
- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
- (2020) Jinyun Dong et al. DRUG RESISTANCE UPDATES
- Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications
- (2020) Francis Boateng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms
- (2020) Mark Borris D. Aldonza et al. Science Advances
- Microtubule engagement with taxane is altered in taxane-resistant gastric cancer
- (2020) Giuseppe Galletti et al. CLINICAL CANCER RESEARCH
- Intratumoral Comparison of Nanoparticle Entrapped Docetaxel (CPC634) with Conventional Docetaxel in Patients with Solid Tumors
- (2020) Florence Atrafi et al. CLINICAL CANCER RESEARCH
- Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
- (2020) Sabrina Dallavalle et al. DRUG RESISTANCE UPDATES
- Nanomedicine to target multidrug resistant tumors
- (2020) Elise Lepeltier et al. DRUG RESISTANCE UPDATES
- Taxane resistance in prostate cancer is mediated by decreased drug-target engagement
- (2020) Ada Gjyrezi et al. JOURNAL OF CLINICAL INVESTIGATION
- Improved melanoma suppression with target-delivered TRAIL and PaclitaxSel by a multifunctional nanocarrier
- (2020) Shiqi Huang et al. JOURNAL OF CONTROLLED RELEASE
- Two-Phase Synthesis of Taxol
- (2020) Yuzuru Kanda et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Noncoding RNAs in gastric cancer: implications for drug resistance
- (2020) Ling Wei et al. Molecular Cancer
- Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance
- (2020) Ping Zhong et al. MOLECULAR PHARMACEUTICS
- Paradoxical mitotic exit induced by a small molecule inhibitor of APC/CCdc20
- (2020) Katherine V. Richeson et al. Nature Chemical Biology
- Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment
- (2020) Angela Flavia Serpico et al. Cell Death & Disease
- The prognostic role of microRNA in epithelial ovarian cancer: a systematic review of literature with an overall survival meta-analysis
- (2020) Patricia Ferreira et al. Oncotarget
- Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target
- (2020) Theo Battista et al. Cancers
- The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane
- (2020) Michal Stark et al. Cells
- Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs
- (2020) Mahendran Chinnappan et al. CANCER LETTERS
- Two-Phase Total Synthesis of Taxanes: Tactics and Strategies
- (2020) Yuzuru Kanda et al. JOURNAL OF ORGANIC CHEMISTRY
- Epigenetic switch-induced viral mimicry evasion in chemotherapy resistant breast cancer
- (2020) Genevieve Deblois et al. Cancer Discovery
- DNA Replication Stress and Chromosomal Instability: Dangerous Liaisons
- (2020) Therese Wilhelm et al. Genes
- Structural definition of polyspecific compensatory ligand recognition by P-glycoprotein
- (2020) Christina A. Le et al. IUCrJ
- Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
- (2020) Elizabeth Varghese et al. Cancers
- A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumours
- (2020) Florence Atrafi et al. JOURNAL OF CONTROLLED RELEASE
- Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
- (2020) Nuray Erin et al. DRUG RESISTANCE UPDATES
- Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
- (2019) Xiaofu Qiu et al. BMC CANCER
- Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel
- (2019) Benjamin Targa et al. Cell Death & Disease
- The Biguanides Metformin and Buformin in Combination with 2-Deoxy-glucose or WZB-117 Inhibit the Viability of Highly Resistant Human Lung Cancer Cells
- (2019) Juan Sebastian Yakisich et al. Stem Cells International
- Structural insight into substrate and inhibitor discrimination by human P-glycoprotein
- (2019) Amer Alam et al. SCIENCE
- The multiple mechanisms that regulate p53 activity and cell fate
- (2019) Antonina Hafner et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy
- (2019) Alexis Fong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tubulin heterogeneity regulates functions and dynamics of microtubules and plays a role in the development of drug resistance in cancer
- (2019) Shweta Shyam Prassanawar et al. BIOCHEMICAL JOURNAL
- EZH2 Confers Sensitivity of Breast Cancer Cells to Taxol by Attenuating p21 Expression Epigenetically
- (2019) Xin Mu et al. DNA AND CELL BIOLOGY
- HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity
- (2019) Basmina Parmakhtiar et al. MOLECULAR CANCER RESEARCH
- Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors
- (2019) Reza Dastvan et al. SCIENCE
- FoxM1 Induced Paclitaxel Resistance via Activation of FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of ABCA2 Transporter
- (2019) Chao Huang et al. Molecular Therapy-Oncolytics
- Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis
- (2019) Wei-Min Chung et al. Cancers
- Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer
- (2019) Ravit Edelman et al. Pharmaceutics
- The emerging role of noncoding RNAs in colorectal cancer chemoresistance
- (2019) Ling Wei et al. CELLULAR ONCOLOGY
- What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
- (2019) Teodora Alexa-Stratulat et al. DRUG RESISTANCE UPDATES
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
- (2019) Abhilash D Pandya et al. International Journal of Nanomedicine
- Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance
- (2019) Masoud Najafi et al. LIFE SCIENCES
- Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo
- (2019) Shira Engelberg et al. Cell Death & Disease
- Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells
- (2019) Daniele Cretella et al. Scientific Reports
- Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin
- (2019) Hao Lin et al. BIOCHEMICAL PHARMACOLOGY
- Towards the overcoming of anticancer drug resistance mediated by p53 mutations
- (2019) Xin Cao et al. DRUG RESISTANCE UPDATES
- Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance
- (2019) M. Helena Vasconcelos et al. DRUG RESISTANCE UPDATES
- Extracellular vesicles and anti-Cancer drug resistance
- (2018) Niamh Mc Namee et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- High expression of class III β-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs
- (2018) Aleksandar Radakovic et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
- (2018) Rochanawan Sootichote et al. BMC CANCER
- Impact of Drug Metabolism/Pharmacokinetics and Their Relevance upon Taxus-based Drug Development
- (2018) Da-Cheng Hao et al. CURRENT DRUG METABOLISM
- How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
- (2018) Philippe Icard et al. DRUG RESISTANCE UPDATES
- How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
- (2018) Thorsten Stiewe et al. DRUG RESISTANCE UPDATES
- Redundant angiogenic signaling and tumor drug resistance
- (2018) Rajesh N. Gacche et al. DRUG RESISTANCE UPDATES
- Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line
- (2018) Aycan Asik et al. GENE
- Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery
- (2018) Iwao Ojima et al. JOURNAL OF NATURAL PRODUCTS
- Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations
- (2018) Myung Soo Kim et al. Nanomedicine-Nanotechnology Biology and Medicine
- Determinants and clinical implications of chromosomal instability in cancer
- (2018) Laurent Sansregret et al. Nature Reviews Clinical Oncology
- Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo
- (2018) Aditya Parekh et al. ONCOGENE
- Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1
- (2018) Amer Alam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia and Noncoding RNAs in Taxane Resistance
- (2018) Perla Pucci et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway
- (2018) Dongshao Chen et al. Cell Death & Disease
- Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78
- (2018) Youli Cai et al. Cell Death & Disease
- Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response
- (2018) Xiaobin Zheng et al. Oncotarget
- Cancer cell-selective, clathrin-mediated endocytosis of aptamerdecorated nanoparticles
- (2018) Shira Engelberg et al. Oncotarget
- Participation of CCL1 in Snail-Positive Fibroblasts in Colorectal Cancer Contribute to 5-Fluorouracil/Paclitaxel Chemoresistance
- (2018) Ziqian Li et al. Cancer Research and Treatment
- Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
- (2018) Karen A. Autio et al. JAMA Oncology
- Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
- (2018) Brandon Bumbaca et al. Acta Pharmaceutica Sinica B
- Current taxane formulations and emerging cabazitaxel delivery systems
- (2018) Boyang Sun et al. Nano Research
- Nuclear envelope assembly defects link mitotic errors to chromothripsis
- (2018) Shiwei Liu et al. NATURE
- Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol
- (2018) Faezeh Asghari et al. Advances in Clinical and Experimental Medicine
- Mutant p53 as a guardian of the cancer cell
- (2018) Fiamma Mantovani et al. CELL DEATH AND DIFFERENTIATION
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- (2018) Piyush B. Gupta et al. Cell Stem Cell
- Modulating ROS to overcome multidrug resistance in cancer
- (2018) Qingbin Cui et al. DRUG RESISTANCE UPDATES
- Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
- (2018) Amit Mahipal et al. INVESTIGATIONAL NEW DRUGS
- Site occupancy calibration of taxane pharmacology in live cells and tissues
- (2018) Javier J. Pineda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity
- (2018) Benny Zhitomirsky et al. Cell Death & Disease
- Reversing multi-drug tumor resistance to Paclitaxel by well-defined pH-sensitive amphiphilic polypeptide block copolymers via induction of lysosomal membrane permeabilization
- (2018) Hassan Mostoufi et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Tubulin Post-Translational Modifications and Microtubule Dynamics
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Zampanolide, a Microtubule-Stabilizing Agent, Is Active in Resistant Cancer Cells and Inhibits Cell Migration
- (2017) Jessica Field et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Taxol®: The First Microtubule Stabilizing Agent
- (2017) Chia-Ping Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paclitaxel: What has been done and the challenges remain ahead
- (2017) Ezequiel Bernabeu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
- (2017) Allimuthu T. Dharmaraja JOURNAL OF MEDICINAL CHEMISTRY
- Tubulin isoform composition tunes microtubule dynamics
- (2017) Annapurna Vemu et al. MOLECULAR BIOLOGY OF THE CELL
- Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein
- (2017) Brandy Verhalen et al. NATURE
- Tubulin acetylation protects long-lived microtubules against mechanical ageing
- (2017) Didier Portran et al. NATURE CELL BIOLOGY
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Microtubules acquire resistance from mechanical breakage through intralumenal acetylation
- (2017) Zhenjie Xu et al. SCIENCE
- Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma
- (2017) Kelly Gaudelot et al. TUMOR BIOLOGY
- Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells
- (2017) Ilaria Genovese et al. Cell Death & Disease
- The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
- (2017) Youxiang Hou et al. Cell Death & Disease
- Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells
- (2017) Yingchun Qu et al. Oncology Letters
- Analysis of resistance-associated gene expression in docetaxel-resistant prostate cancer cells
- (2017) Sangchul Lee et al. Oncology Letters
- Prolonged mitotic arrest induced by Wee1 inhibition sensitizes breast cancer cells to paclitaxel
- (2017) Cody W. Lewis et al. Oncotarget
- Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
- (2017) Radosław Januchowski et al. Oncotarget
- Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells
- (2017) Floriana Morgillo et al. Oncotarget
- MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells
- (2017) Hyebin Koh et al. Oncotarget
- Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
- (2017) Benny Zhitomirsky et al. Oncotarget
- Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
- (2017) T. J. Mitchison et al. Open Biology
- Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance
- (2017) Duncan Ayers et al. Genes
- Tesetaxel, a novel oral taxane, as second-line therapy for advanced gastroesophageal cancer: Activity in a dose-ranging study.
- (2017) Jaffer A. Ajani et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function
- (2017) I. Kalhari Lindamulage et al. Scientific Reports
- Mechanisms of Primary and Secondary Resistance to Imatinib in Chronic Myeloid Leukemia
- (2017) Alfonso Quintás-Cardama et al. Cancer Control
- Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
- (2016) Anju Singh et al. ACS Chemical Biology
- Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel
- (2016) Sayaka Sobue et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancer
- (2016) W. Wang et al. BIOSCIENCE REPORTS
- The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells
- (2016) Stine Ninel Hansen et al. BMC GENOMICS
- Hallmarks of cancer stem cell metabolism
- (2016) Patricia Sancho et al. BRITISH JOURNAL OF CANCER
- The complexity of integrins in cancer and new scopes for therapeutic targeting
- (2016) Hellyeh Hamidi et al. BRITISH JOURNAL OF CANCER
- Microtubule destabilising agents: far more than just antimitotic anticancer drugs
- (2016) Darcy Bates et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies
- (2016) H.-S. Lee et al. CANCER RESEARCH
- Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
- (2016) D. D. Von Hoff et al. CLINICAL CANCER RESEARCH
- Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells
- (2016) Aaron M. Hosios et al. DEVELOPMENTAL CELL
- Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
- (2016) Ruud H. Wijdeven et al. DRUG RESISTANCE UPDATES
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Tyrosination of α‐tubulin controls the initiation of processive dynein–dynactin motility
- (2016) Richard J McKenney et al. EMBO JOURNAL
- ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview
- (2016) Elena Arrigoni et al. Expert Opinion on Drug Metabolism & Toxicology
- Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity
- (2016) Lothar Esser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles
- (2016) Wanting Zou et al. JOURNAL OF DRUG TARGETING
- Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
- (2016) Roberta Visconti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma
- (2016) Hongfang Zhang et al. MOLECULAR CARCINOGENESIS
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
- (2016) Myung Soo Kim et al. Nanomedicine-Nanotechnology Biology and Medicine
- The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults
- (2016) Małgorzata Nita et al. Oxidative Medicine and Cellular Longevity
- 2-(m-Azidobenzoyl)taxol binds differentially to distinct β-tubulin isotypes
- (2016) Chia-Ping Huang Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters
- (2016) Vlasta Němcová-Fürstová et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer
- (2016) Jan Kroon et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer
- (2016) PATRICK LEBOK et al. Oncology Letters
- Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
- (2016) Jhih-Pu Syu et al. Oncotarget
- Multidrug Resistance Proteins (MRPs) and Cancer Therapy
- (2015) Yun-Kai Zhang et al. AAPS Journal
- Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
- (2015) Jintong Du et al. BMC CANCER
- Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
- (2015) Yu Yu et al. CANCER CELL
- Treatment regimens of classical and newer taxanes
- (2015) Markus Joerger CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma
- (2015) Tommaso Azzarito et al. CANCER LETTERS
- FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition
- (2015) Zhijiao Zhou et al. CANCER LETTERS
- Elucidating the Mechanism of Action of the Clinically Approved Taxanes: A Comprehensive Comparison of Local and Allosteric Effects
- (2015) Cassandra D. M. Churchill et al. Chemical Biology & Drug Design
- Notch Pathway Inhibition Using PF-03084014, a -Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer
- (2015) D. Cui et al. CLINICAL CANCER RESEARCH
- Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
- (2015) Sophie Taylor et al. DRUG RESISTANCE UPDATES
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
- (2015) S. Meidhof et al. EMBO Molecular Medicine
- Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer
- (2015) Robert J. van Soest et al. EUROPEAN UROLOGY
- Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model
- (2015) Jeroen J.M.A. Hendrikx et al. INTERNATIONAL JOURNAL OF CANCER
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway
- (2015) Cuixia Yang et al. MEDICAL ONCOLOGY
- Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer
- (2015) M. Talekar et al. MOLECULAR CANCER THERAPEUTICS
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
- (2015) P Khongkow et al. ONCOGENE
- Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
- (2015) Renata Silva et al. PHARMACOLOGY & THERAPEUTICS
- Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
- (2015) Haiquan Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of SPARC expression in pancreatic cancer progression and patient survival
- (2015) Chinmay Gundewar et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
- (2015) N Mohell et al. Cell Death & Disease
- IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
- (2015) Zhen Ning Wee et al. Nature Communications
- MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs
- (2015) Yang Zhao et al. Drug Design Development and Therapy
- Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma
- (2015) Inik Chang et al. Oncotarget
- Structural basis of Sorcin-mediated calcium-dependent signal transduction
- (2015) Andrea Ilari et al. Scientific Reports
- TaxKB: a knowledge base for new taxane-related drug discovery
- (2015) Kasi Murugan et al. BioData Mining
- Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
- (2015) Nirmala Chandralega Kampan et al. Biomed Research International
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein
- (2015) Paul Szewczyk et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway
- (2015) WEIPENG ZHANG et al. Molecular Medicine Reports
- Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5
- (2015) Prisca Exertier et al. Oncotarget
- βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer
- (2015) Joshua A. McCarroll et al. Oncotarget
- Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
- (2015) Benny Zhitomirsky et al. Oncotarget
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- The Quest for a Simple Bioactive Analog of Paclitaxel as a Potential Anticancer Agent
- (2014) David G. I. Kingston et al. ACCOUNTS OF CHEMICAL RESEARCH
- Reversing Effect of Sorcin in the Drug Resistance of Human Nasopharyngeal Carcinoma
- (2014) Xuebing Liu et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- The multifaceted regulation and functions of PKM2 in tumor progression
- (2014) Zongwei Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line
- (2014) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances
- (2014) Ruth Matesanz et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
- (2014) Gregory M. Alushin et al. CELL
- Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells
- (2014) J Bargiela-Iparraguirre et al. CELL CYCLE
- Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel
- (2014) J. E. Abraham et al. CLINICAL CANCER RESEARCH
- Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon
- (2014) C. Rocha et al. EMBO JOURNAL
- Dual Inhibition of Phosphatidylinositol 3′-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach for Mucinous Adenocarcinoma of the Ovary
- (2014) Akiko Kudoh et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer
- (2014) VIVIANA CASTILLO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells
- (2014) YOUNG-AH SUH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The tubulin code: Molecular components, readout mechanisms, and functions
- (2014) Carsten Janke JOURNAL OF CELL BIOLOGY
- 3-Methyladenine can depress drug efflux transporters via blocking the PI3K–AKT–mTOR pathway thus sensitizing MDR cancer to chemotherapy
- (2014) Zhenyou Zou et al. JOURNAL OF DRUG TARGETING
- NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells
- (2014) Cheng Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Mechanisms of Resistance to Cabazitaxel
- (2014) G. E. Duran et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
- (2014) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities
- (2014) Cristina C. Rohena et al. NATURAL PRODUCT REPORTS
- Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C
- (2014) Katharine L. Sackton et al. NATURE
- Regulation of microtubule motors by tubulin isotypes and post-translational modifications
- (2014) Minhajuddin Sirajuddin et al. NATURE CELL BIOLOGY
- Sorcin Links Calcium Signaling to Vesicle Trafficking, Regulates Polo-Like Kinase 1 and Is Necessary for Mitosis
- (2014) Vasiliki S. Lalioti et al. PLoS One
- Chronic Oxidative Stress Increases Growth and Tumorigenic Potential of MCF-7 Breast Cancer Cells
- (2014) Prathap Kumar S. Mahalingaiah et al. PLoS One
- A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth
- (2014) Liwei Lang et al. PLoS One
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
- (2014) L. M. Zasadil et al. Science Translational Medicine
- Extracellular vesicles: emerging targets for cancer therapy
- (2014) Pieter Vader et al. TRENDS IN MOLECULAR MEDICINE
- Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein
- (2014) Meng-meng Lv et al. TUMOR BIOLOGY
- Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-α-mediated signaling
- (2014) X Peng et al. Cell Death & Disease
- Regulation and Role of EZH2 in Cancer
- (2014) Hirohito Yamaguchi et al. Cancer Research and Treatment
- Regulated Splicing of the α6 Integrin Cytoplasmic Domain Determines the Fate of Breast Cancer Stem Cells
- (2014) Hira Lal Goel et al. Cell Reports
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Microtubules and Their Role in Cellular Stress in Cancer
- (2014) Amelia L. Parker et al. Frontiers in Oncology
- Rationally designed nanovehicles to overcome cancer chemoresistance
- (2013) Yoav D. Livney et al. ADVANCED DRUG DELIVERY REVIEWS
- The pharmacological bases of the antiangiogenic activity of paclitaxel
- (2013) Guido Bocci et al. ANGIOGENESIS
- Clinical and economic implications of the use of nanoparticle paclitaxel (Nanoxel) in India
- (2013) A. A. Ranade et al. ANNALS OF ONCOLOGY
- Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Identification and analysis of CD133+ melanoma stem-like cells conferring resistance to taxol: An insight into the mechanisms of their resistance and response
- (2013) Abdelouahid El-Khattouti et al. CANCER LETTERS
- Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy
- (2013) Serena Giovinazzi et al. CELL CYCLE
- Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options
- (2013) Elias J. Jabbour et al. Clinical Lymphoma Myeloma & Leukemia
- Increased α-Tubulin1b Expression Indicates Poor Prognosis and Resistance to Chemotherapy in Hepatocellular Carcinoma
- (2013) Cuihua Lu et al. DIGESTIVE DISEASES AND SCIENCES
- Taxane Mechanisms of Action: Potential Implications for Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer
- (2013) John M. Fitzpatrick et al. EUROPEAN UROLOGY
- SPARC independent drug delivery and antitumour effects ofnab-paclitaxel in genetically engineered mice
- (2013) Albrecht Neesse et al. GUT
- Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway
- (2013) Jie Ni et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Therapy-induced enrichment of putative lung cancer stem-like cells
- (2013) Daniela P. Freitas et al. INTERNATIONAL JOURNAL OF CANCER
- Increased Chemosensitivity via Targeting Testicular Nuclear Receptor 4 (TR4)-Oct4-Interleukin 1 Receptor Antagonist (IL1Ra) Axis in Prostate Cancer CD133+Stem/Progenitor Cells to Battle Prostate Cancer
- (2013) Dong-Rong Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer
- (2013) Yu Kang et al. JNCI-Journal of the National Cancer Institute
- Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1
- (2013) Francesca Maddalena et al. Molecular Oncology
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
- (2013) P Khongkow et al. ONCOGENE
- Synthesis and biological evaluation of new paclitaxel analogs and discovery of potent antitumor agents
- (2013) Kyriacos C. Nicolaou et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain
- (2013) A. B. Ward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
- (2013) Jun-Eul Hwang et al. YONSEI MEDICAL JOURNAL
- Extracellular Vesicles – Biomarkers and Effectors of the Cellular Interactome in Cancer
- (2013) Janusz Rak Frontiers in Pharmacology
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Expression of β-tubulin III and Survivin in Advance Stage Breast Cancer Correlates with Chemotheraputic Effects of Docetaxel
- (2012) Shao-Fei Yuan et al. Asian Pacific Journal of Cancer Prevention
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Mitochondrial uncoupling protein 2 regulates the effects of paclitaxel on Stat3 activation and cellular survival in lung cancer cells
- (2012) Wen-Pin Su et al. CARCINOGENESIS
- Inhibitors Targeting Mitosis: Tales of How Great Drugs against a Promising Target Were Brought Down by a Flawed Rationale
- (2012) E. Komlodi-Pasztor et al. CLINICAL CANCER RESEARCH
- Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma
- (2012) J.-P. Gillet et al. CLINICAL CANCER RESEARCH
- The UCSF-FDA TransPortal: A Public Drug Transporter Database
- (2012) K M Morrissey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
- (2012) A. Palmeira et al. CURRENT MEDICINAL CHEMISTRY
- Novel Drugs Targeting Microtubules: the Role of Epothilones
- (2012) Gabriella Ferrandina et al. CURRENT PHARMACEUTICAL DESIGN
- Collateral sensitivity as a strategy against cancer multidrug resistance
- (2012) Kristen M. Pluchino et al. DRUG RESISTANCE UPDATES
- P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel
- (2012) Jeroen J.M.A. Hendrikx et al. INTERNATIONAL JOURNAL OF CANCER
- First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
- (2012) Jonas Bergh et al. JOURNAL OF CLINICAL ONCOLOGY
- Liposomal paclitaxel formulations
- (2012) Štěpán Koudelka et al. JOURNAL OF CONTROLLED RELEASE
- The effect of some antineoplastic agents on glutathioneS-transferase from human erythrocytes
- (2012) Mustafa Erat et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Genetic heterogeneity and cancer drug resistance
- (2012) Nicholas C Turner et al. LANCET ONCOLOGY
- Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies
- (2012) Li-nian Huang et al. MOLECULAR BIOLOGY REPORTS
- ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
- (2012) David A Tumbarello et al. Molecular Cancer
- DNA breaks and chromosome pulverization from errors in mitosis
- (2012) Karen Crasta et al. NATURE
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis
- (2012) Mar Carmena et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
- (2012) Claire Corcoran et al. PLoS One
- Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heart
- (2012) K. Krishnamurthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
- (2012) G M A Ajabnoor et al. Cell Death & Disease
- Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain function
- (2012) David O. Kennedy et al. Advances in Nutrition
- Upsides and Downsides of Reactive Oxygen Species for Cancer: The Roles of Reactive Oxygen Species in Tumorigenesis, Prevention, and Therapy
- (2011) Subash C. Gupta et al. ANTIOXIDANTS & REDOX SIGNALING
- Src family kinases and paclitaxel sensitivity
- (2011) Xiao-Feng Le et al. CANCER BIOLOGY & THERAPY
- Sorcin Induces a Drug-Resistant Phenotype in Human Colorectal Cancer by Modulating Ca2+ Homeostasis
- (2011) F. Maddalena et al. CANCER RESEARCH
- Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10-/- Mice
- (2011) E. A. Hopper-Borge et al. CANCER RESEARCH
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
- (2011) Y. Zhou et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Natural Taxanes: Developments Since 1828
- (2011) Yu-Fang Wang et al. CHEMICAL REVIEWS
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review
- (2011) Naseem Akhtar et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
- (2011) Benjamin Boyerinas et al. INTERNATIONAL JOURNAL OF CANCER
- Mitotic Centromere-associated Kinesin (MCAK) Mediates Paclitaxel Resistance
- (2011) Anutosh Ganguly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system
- (2011) Sa-Won Lee et al. JOURNAL OF CONTROLLED RELEASE
- Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer
- (2011) Fiona Furlong et al. JOURNAL OF PATHOLOGY
- Long-Term Androgen Ablation and Docetaxel Up-Regulate Phosphorylated Akt in Castration Resistant Prostate Cancer
- (2011) Takeo Kosaka et al. JOURNAL OF UROLOGY
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- Overexpression of Mitotic Centromere-Associated Kinesin Stimulates Microtubule Detachment and Confers Resistance to Paclitaxel
- (2011) A. Ganguly et al. MOLECULAR CANCER THERAPEUTICS
- Mitosis is not a key target of microtubule agents in patient tumors
- (2011) Edina Komlodi-Pasztor et al. Nature Reviews Clinical Oncology
- Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling
- (2011) Lu Gan et al. PROSTATE
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Relocation of Aurora B and Survivin from Centromeres to the Central Spindle Impaired by a Kinesin-Specific MKLP-2 Inhibitor
- (2010) Sergey Tcherniuk et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces A Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle Damage
- (2010) Xing Zeng et al. CANCER CELL
- Class III -Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy
- (2010) G. Ploussard et al. CANCER RESEARCH
- Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
- (2010) M.-L. Zhu et al. CANCER RESEARCH
- The β isotypes of tubulin in neuronal differentiation
- (2010) Jiayan Guo et al. Cytoskeleton
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer
- (2010) Francesco Crea et al. INTERNATIONAL JOURNAL OF CANCER
- ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells
- (2010) Siddik Sarkar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-Positive Breast Cancer
- (2010) Sherry X. Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors
- (2010) Yuping Liu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells
- (2010) Meisong Lu et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Activation of the cardiac Na+–Ca2+ exchanger by sorcin via the interaction of the respective Ca2+-binding domains
- (2010) Carlotta Zamparelli et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
- (2010) Ming Zhou et al. Molecular Cancer
- Cytotoxic Effects Induced by Docetaxel, Gefitinib, and Cyclopamine on Side Population and Nonside Population Cell Fractions from Human Invasive Prostate Cancer Cells
- (2010) M. Mimeault et al. MOLECULAR CANCER THERAPEUTICS
- Human Mutations That Confer Paclitaxel Resistance
- (2010) S. Yin et al. MOLECULAR CANCER THERAPEUTICS
- Cabazitaxel
- (2010) Matthew D. Galsky et al. NATURE REVIEWS DRUG DISCOVERY
- Phenotype prediction of nonsynonymous single nucleotide polymorphisms in human phase II drug/xenobiotic metabolizing enzymes: perspectives on molecular evolution
- (2010) DaCheng Hao et al. Science China-Life Sciences
- Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel
- (2009) Dan Su et al. CANCER
- Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer
- (2009) L. Gan et al. CANCER RESEARCH
- Advances and Challenges in Basic and Translational Research on Clusterin
- (2009) I. P. Trougakos et al. CANCER RESEARCH
- A mutation in β-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line
- (2009) Takahito Hara et al. CELL BIOLOGY INTERNATIONAL
- Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors
- (2009) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Targeting the PI3K signaling pathway in cancer
- (2009) Kwok-Kin Wong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Paclitaxel-resistance Conferred by Altered Expression of Efflux and Influx Transporters for Paclitaxel in the Human Hepatoma Cell Line, HepG2
- (2009) Mikihisa Takano et al. Drug Metabolism and Pharmacokinetics
- Class III β-Tubulin Expression in Tumor Cells is Correlated with Resistance to Docetaxel in Patients with Completely Resected Non-Small-Cell Lung Cancer
- (2009) Yoshiki Hayashi et al. INTERNAL MEDICINE
- How do anti-mitotic drugs kill cancer cells?
- (2009) K. E. Gascoigne et al. JOURNAL OF CELL SCIENCE
- Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β-tubulin
- (2009) Christos D. Katsetos et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Identification and Characterization of an Intermediate Taxol Binding Site Within Microtubule Nanopores and a Mechanism for Tubulin Isotype Binding Selectivity
- (2009) Holly Freedman et al. Journal of Chemical Information and Modeling
- Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma
- (2009) Steven O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
- (2009) Robert Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance
- (2009) Yogesh Patil et al. JOURNAL OF CONTROLLED RELEASE
- Posttranslational Modifications of Tubulin and the Polarized Transport of Kinesin-1 in Neurons
- (2009) Jennetta W. Hammond et al. MOLECULAR BIOLOGY OF THE CELL
- Ixabepilone: targeting III-tubulin expression in taxane-resistant malignancies
- (2009) C. Dumontet et al. MOLECULAR CANCER THERAPEUTICS
- Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells
- (2009) Srinivas Ganta et al. MOLECULAR PHARMACEUTICS
- Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells
- (2009) Mariko Muta et al. ONCOLOGY
- Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells
- (2009) Aniek Janssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer
- (2009) A. E. Sayan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: Implications for PSA surrogacy
- (2009) Kenji Kuroda et al. PROSTATE
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1®
- (2008) Robert W. Robey et al. BIOCHEMICAL PHARMACOLOGY
- Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis
- (2008) Steffen Blenk et al. BMC CANCER
- Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells
- (2008) G E Konecny et al. BRITISH JOURNAL OF CANCER
- Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs
- (2008) Karen E. Gascoigne et al. CANCER CELL
- Mechanisms of ROS modulated cell survival during carcinogenesis
- (2008) J.S. Clerkin et al. CANCER LETTERS
- Molecular Mechanisms of Patupilone Resistance
- (2008) S. Mozzetti et al. CANCER RESEARCH
- The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
- (2008) April L. Risinger et al. CANCER RESEARCH
- Stathmin 1: a novel therapeutic target for anticancer activity
- (2008) Shushan Rana et al. Expert Review of Anticancer Therapy
- Microtubules: A dynamic target in cancer therapy
- (2008) Eddy Pasquier et al. IUBMB LIFE
- Design, Synthesis, and Biological Evaluation of New-Generation Taxoids
- (2008) Iwao Ojima et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stathmin Activity Influences Sarcoma Cell Shape, Motility, and Metastatic Potential
- (2008) Barbara Belletti et al. MOLECULAR BIOLOGY OF THE CELL
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
- (2008) J. M-M. Kwok et al. MOLECULAR CANCER THERAPEUTICS
- Autophagy fights disease through cellular self-digestion
- (2008) Noboru Mizushima et al. NATURE
- Tracking the ends: a dynamic protein network controls the fate of microtubule tips
- (2008) Anna Akhmanova et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
- (2008) S.-F. Zhou XENOBIOTICA
- The roles of cys124 and ser239 in the functional properties of human βIII tubulin
- (2008) Patrick A. Joe et al. CELL MOTILITY AND THE CYTOSKELETON
- The ability to survive mitosis in the presence of microtubule poisons differs significantly between human nontransformed (RPE-1) and cancer (U2OS, HeLa) cells
- (2008) Daniela A. Brito et al. CELL MOTILITY AND THE CYTOSKELETON
- Taxanes, microtubules and chemoresistant breast cancer
- (2007) Barbara T. McGrogan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Molecular basis for the impaired function of the natural F112L sorcin mutant: X-ray crystal structure, calcium affinity, and interaction with annexin VII and the ryanodine receptor
- (2007) Stefano Franceschini et al. FASEB JOURNAL
- Hypoxia induces class III beta-tubulin gene expression by HIF-1α binding to its 3' flanking region
- (2007) Giuseppina Raspaglio et al. GENE
- P-glycoprotein: So Many Ways to Turn It On
- (2007) Richard Callaghan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now